4//SEC Filing
Peters Jeffrey Stuart 4
Accession 0001125345-24-000063
CIK 0001125345other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:14 PM ET
Size
11.7 KB
Accession
0001125345-24-000063
Insider Transaction Report
Form 4
MACROGENICS INCMGNX
Peters Jeffrey Stuart
Senior VP and General Counsel
Transactions
- Exercise/Conversion
Common Stock
2024-03-06$11.50/sh+10,875$125,063→ 19,770 total - Sale
Common Stock
2024-03-06$21.50/sh−19,625$421,938→ 8,895 total - Exercise/Conversion
Common Stock
2024-03-06$10.15/sh+8,750$88,813→ 28,520 total - Exercise/Conversion
Employee stock option (right to buy)
2024-03-06$10.15/sh−8,750$88,813→ 39,375 totalExercise: $10.15Exp: 2032-02-22→ Common Stock (8,750 underlying) - Exercise/Conversion
Employee stock option (right to buy)
2024-03-06$11.50/sh−10,875$125,063→ 0 totalExercise: $11.50Exp: 2030-02-20→ Common Stock (10,875 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/10/2022.
- [F2]12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
Documents
Issuer
MACROGENICS INC
CIK 0001125345
Entity typeother
Related Parties
1- filerCIK 0001706903
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:14 PM ET
- Size
- 11.7 KB